Regeneron Pharmaceuticals (REGN) Shareholder's Equity Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.93% |
| Dec 31, 2025 | 6.48% |
| Sep 30, 2025 | 5.56% |
| Jun 30, 2025 | 6.14% |
| Mar 31, 2025 | 8.88% |
| Dec 31, 2024 | 13.02% |
| Sep 30, 2024 | 17.75% |
| Jun 30, 2024 | 17.44% |
| Mar 31, 2024 | 14.88% |
| Dec 31, 2023 | 14.60% |
| Sep 30, 2023 | 16.17% |
| Jun 30, 2023 | 16.10% |
| Mar 31, 2023 | 17.98% |
| Dec 31, 2022 | 20.75% |
| Sep 30, 2022 | 24.23% |
| Jun 30, 2022 | 36.76% |
| Mar 31, 2022 | 66.27% |
| Dec 31, 2021 | 70.23% |
| Sep 30, 2021 | 70.44% |
| Jun 30, 2021 | 67.02% |
| Mar 31, 2021 | -1.29% |
| Dec 31, 2020 | -0.58% |
| Sep 30, 2020 | -3.61% |
| Jun 30, 2020 | -7.16% |
| Mar 31, 2020 | 28.46% |
| Dec 31, 2019 | 26.63% |
| Sep 30, 2019 | 33.50% |
| Jun 30, 2019 | 35.76% |
| Mar 31, 2019 | 43.81% |
| Dec 31, 2018 | 42.53% |
| Sep 30, 2018 | 30.02% |
| Jun 30, 2018 | 30.17% |
| Mar 31, 2018 | 34.97% |
| Dec 31, 2017 | 38.09% |
| Sep 30, 2017 | 34.74% |
| Jun 30, 2017 | 35.43% |
| Mar 31, 2017 | 29.24% |
| Dec 31, 2016 | 21.74% |
| Sep 30, 2016 | 36.23% |
| Jun 30, 2016 | 22.11% |
| Mar 31, 2016 | 26.71% |
| Dec 31, 2015 | 43.31% |
| Sep 30, 2015 | 29.20% |
| Jun 30, 2015 | 40.93% |
| Mar 31, 2015 | 34.38% |
| Dec 31, 2014 | 29.80% |
| Sep 30, 2014 | 50.98% |
| Jun 30, 2014 | 58.63% |
| Mar 31, 2014 | 57.23% |
| Dec 31, 2013 | 56.35% |
| Sep 30, 2013 | 109.69% |
| Jun 30, 2013 | 151.13% |
| Mar 31, 2013 | 4,668.14% |
| Dec 31, 2012 | 158.71% |
| Sep 30, 2012 | 88.21% |
| Jun 30, 2012 | 24.40% |
| Mar 31, 2012 | -105.94% |
| Dec 31, 2011 | -7.97% |
| Sep 30, 2011 | 23.04% |
| Jun 30, 2011 | 28.78% |
| Mar 31, 2011 | 34.13% |
| Dec 31, 2010 | 33.03% |
| Sep 30, 2010 | -17.61% |
| Jun 30, 2010 | -9.57% |